Platelet-lymphocyte ratio predicts survival in patients with hepatocellular carcinoma who receive lenvatinib: an inverse probability weighting analysis
| Image |  |
|---|---|
| Description | scientific article published on 10 April 2020 |
| Author/s |
author: Kojiro Michitaka Norio Itokawa Noritomo Shimada Korenobu Hayama Akemi Tsutsui Yohei Koizumi Taeang Arai Real-life Practice Experts for HCC (RELPEC) Study Group and the HCC 48 Group (hepatocellular carcinoma experts from 48 clinics in Japan) Hidenori Toyoda Yoichi Hiasa Hironori Ochi Atsushi Hiraoka Kouji Joko Kazuto Tajiri Koichi Takaguchi Michitaka Imai Toru Ishikawa Kazuhito Kawata Masanori Atsukawa Masashi Hirooka Takuya Nagano Toshifumi Tada Shinya Fukunishi Kazuhiro Nouso Takashi Kumada Kazuya Kariyama |
| Publication date | April 10, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |